EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study

Vlad Ratziu, Mary E. Rinella, Brent A. Neuschwander-Tetri, Eric Lawitz, Douglas Denham, Zeid Kayali, Aasim Sheikh, Kris V. Kowdley, Taddese Desta, Magdy Elkhashab, Jeffery DeGrauw, Bryan Goodwin, Alaa Ahmad, Nathalie Adda*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

79 Scopus citations

Fingerprint

Dive into the research topics of 'EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science